Research Article
Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence
Table 3
Subgroup analysis based on afatinib medication timing and data sources.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes: PA: value for the test of association; PH: value for the test of heterogeneity. |